Clinical Trials
Screening Trials
Screening trials are designed to discover diseases in their earliest, most treatable stages—often before any symptoms appear. These trials evaluate new methods or procedures to determine whether they are effective at detecting specific health conditions, such as cancer or heart disease, in a large group of people. The ultimate goal is to identify illnesses early and reduce the risk of serious complications or death.
These trials often involve people who do not yet show signs of the condition being studied. Researchers assess whether the screening tool accurately identifies those at risk, and whether it improves health outcomes. By participating in screening trials, individuals contribute to advancements that can lead to better public health strategies and save countless lives through early intervention.
Early Detection
Screening trials aim to identify diseases before symptoms appear, improving treatment outcomes.
Better Prevention
They help evaluate the effectiveness of new tests in reducing illness or death through timely diagnosis.